Skip to content
Search

Latest Stories

India rolls out £2 a dose Oxford vaccine

Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday described the dispatch of Covishield vaccines for the January 16 national inoculation drive a "proud and historic" moment.

Vaccinations are set to begin on Saturday (Jan 9) in an effort that authorities hope will see 300 million high-risk people inoculated over the next six to eight months.


First to get the vaccine will be 30 million health and other frontline workers, followed by about 270 million older than 50 or deemed high-risk.

Early Tuesday, the first consignment of the vaccines rolled out of the SII facility in Pune for transport to various locations in the country.

Speaking to the select media persons at the SII facility, Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable groups of people and to healthcare workers".

"Our trucks left the SII facility early morning and now the vaccine is being distributed in the entire country. This is a proud and historic moment as scientists, experts and all other stake-holders took great efforts while making this vaccine in less than a year," he said.

Poonawalla said the SII has offered the vaccine to the government of India (GoI) at a special price of Rs 200 (just over £2).

"This is one of the most affordable vaccines in the world and we are offering it to the GoI at a special price just to support the (Indian) prime minister's vision and to support the ''aam aadami'' (common man) of our country," he added.

He also said that once the SII get the requisite permission, the vaccine will be made available in the private market at the cost Rs 1,000 (over £10).

Poonawalla further said the SII is not only providing the vaccine in India, "but it is also committed to provide it to other countries who are looking at India at this point".

Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by the SII.

A ''puja'' (ceremonial worship) was performed before the three temperature controlled trucks rolled out of Serum Institute gates shortly before 5 am and moved towards the Pune airport, about 15 km away, from where the vaccines were flown across India.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less